Tissue levels of polyunsaturated fatty acids during early human development
- PMID: 1532827
- DOI: 10.1016/s0022-3476(05)81247-8
Tissue levels of polyunsaturated fatty acids during early human development
Abstract
Long-chain fatty acids are analyzed in tissues from infants whose cause of death was not neurologically related. Total n-3 and n-6 polyunsaturated and n-9 monounsaturated fatty acid amounts increased in the whole forebrain during the prenatal and postnatal periods up to at least 2 years of age. The most abundant brain polyunsaturated fatty acids were docosahexaenoic acid (DHA) (22:6n-3), arachidonic acid (AA) (20:4n-6), and adrenic acid (22:4n-6). In neonates receiving total parenteral nutrition for several days, the DHA/AA ratio was outside the normal range in the liver but within the normal range in the brain. Two other children received total parenteral nutrition for many months, but only the one born at 29 weeks of gestation had a low brain DHA/AA ratio. Another infant, born at 25 weeks of gestation, had been fed milk formulas containing high linoleate/alpha-linolenate ratios for 4 months. This infant had less DHA and a lower DHA/AA ratio in both the brain and the retina than had term infants. These data suggest that preterm infants are especially at risk for the effects of dietary fatty acid imbalances.
Similar articles
-
Growth and development in term infants fed long-chain polyunsaturated fatty acids: a double-masked, randomized, parallel, prospective, multivariate study.Pediatrics. 2001 Aug;108(2):372-81. doi: 10.1542/peds.108.2.372. Pediatrics. 2001. PMID: 11483802 Clinical Trial.
-
Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial.Pediatrics. 2001 Aug;108(2):359-71. doi: 10.1542/peds.108.2.359. Pediatrics. 2001. PMID: 11483801 Clinical Trial.
-
Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age.Pediatrics. 2003 Sep;112(3 Pt 1):e177-83. doi: 10.1542/peds.112.3.e177. Pediatrics. 2003. PMID: 12949309 Clinical Trial.
-
Plasma and red blood cell fatty acid values as indexes of essential fatty acids in the developing organs of infants fed with milk or formulas.J Pediatr. 1992 Apr;120(4 Pt 2):S78-86. doi: 10.1016/s0022-3476(05)81240-5. J Pediatr. 1992. PMID: 1532829 Review.
-
Enteral and parenteral lipid requirements of preterm infants.World Rev Nutr Diet. 2014;110:82-98. doi: 10.1159/000358460. Epub 2014 Apr 11. World Rev Nutr Diet. 2014. PMID: 24751623 Review.
Cited by
-
Neurodevelopmental outcomes at 7 years' corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: a follow-up of a randomised controlled trial.BMJ Open. 2015 Mar 18;5(3):e007314. doi: 10.1136/bmjopen-2014-007314. BMJ Open. 2015. PMID: 25787990 Free PMC article. Clinical Trial.
-
The effects of maternal supplementation of polyunsaturated Fatty acids on visual, neurobehavioural, and developmental outcomes of the child: a systematic review of the randomized trials.Obstet Gynecol Int. 2012;2012:591531. doi: 10.1155/2012/591531. Epub 2012 Jan 18. Obstet Gynecol Int. 2012. PMID: 22315616 Free PMC article.
-
Omega-3/Omega-6 Long-Chain Fatty Acid Imbalance in Phase I Retinopathy of Prematurity.Nutrients. 2022 Mar 23;14(7):1333. doi: 10.3390/nu14071333. Nutrients. 2022. PMID: 35405946 Free PMC article.
-
14,15-epoxyeicosatrienoic acid produced by cytochrome P450s enhances neurite outgrowth of PC12 and rat hippocampal neuronal cells.Pharmacol Res Perspect. 2018 Sep 17;6(5):e00428. doi: 10.1002/prp2.428. eCollection 2018 Oct. Pharmacol Res Perspect. 2018. PMID: 30237892 Free PMC article.
-
Ferroptosis: A Promising Therapeutic Target for Neonatal Hypoxic-Ischemic Brain Injury.Int J Mol Sci. 2022 Jul 4;23(13):7420. doi: 10.3390/ijms23137420. Int J Mol Sci. 2022. PMID: 35806425 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical